Form 4: Biote Corp. Director Andrew R. Heyer Increases Stake with Recent Stock Purchases

Andrew R. Heyer, a director of Biote Corp., has increased his beneficial ownership through recent purchases of Class A Common Stock.

Summary

• On March 17, 2025, Andrew R. Heyer, a director of Biote Corp. (BTMD), purchased 50,000 shares of Class A Common Stock at a weighted average price of $3.9476.
• On the same day, Heyer also purchased 25,000 shares of Class A Common Stock at a weighted average price of $3.9465.
• Following these transactions, Heyer directly owns 1,523,513 shares and indirectly owns 370,201 shares through Heyer Investment Management, LLC.
• He also has indirect ownership through various trusts, including the Harris Reid Heyer Trust, the James Heyer Trust, the Mindy B. Heyer 2021 Grantor Retained Annuity Trust, the Peter Justin Heyer Trust, and the William Heyer Trust, each holding 61,298 shares, except for the Mindy B. Heyer 2021 Grantor Retained Annuity Trust which holds 153,250 shares.
• Heyer disclaims beneficial ownership of the shares held by the Mindy B. Heyer 2021 Grantor Retained Annuity Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director's stock purchase suggests confidence, but it's a routine transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into a company's prospects. Purchases by directors are generally viewed more favorably than sales.

Stakeholder Impact

• The stock purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Beneficial Ownership, BTMD, Biote Corp., Andrew R. Heyer, Insider Trading, Class A Common Stock